List of Studies ( Metabolite:3beta,16alpha-Dihydroxyandrostenone sulfate)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003333 | AN005461 | Urine Metabolite Profiling in Indian Male Population at High Altitude using Liquid Chromatography – Mass Spectrometry: A Longitudinal Pilot Study | Urine | Human | Environmental exposure | Defence Institute of Physiology and Allied Sciences | LC-MS |
| ST003333 | AN005461 | Urine Metabolite Profiling in Indian Male Population at High Altitude using Liquid Chromatography – Mass Spectrometry: A Longitudinal Pilot Study | Urine | Human | Hypoxia | Defence Institute of Physiology and Allied Sciences | LC-MS |
| ST003032 | AN004971 | Effects of Preanalytical Sample Collection and Handling on Comprehensive Metabolite Measurements in Human Urine Biospecimens | Urine | Human | National Center for Advancing Translational Sciences | Other | |
| ST002909 | AN004777 | Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis | Blood | Human | Melioidosis | University of Washington | Other |
| ST002829 | AN004621 | Nucleotide, phospholipid, and kynurenine metabolites are robustly associated with COVID-19 severity and time of plasma sample collection in a prospective cohort study | Blood | Human | COVID-19 | National Institutes of Health | Other |
| ST002820 | AN004596 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) | Blood | Human | Tufts Medical Center | Other | |
| ST002819 | AN004592 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) | Blood | Human | Tufts Medical Center | Other | |
| ST002818 | AN004588 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) | Blood | Human | Tufts Medical Center | Other | |
| ST002155 | AN003530 | Longitudinal metabolomic stool dynamics in primary C. difficile infections | Feces | Human | Bacterial infection | Brigham and Women's Hospital | LC-MS |
| ST002094 | AN003420 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | LC-MS |
| ST002094 | AN003422 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | LC-MS |
| ST002020 | AN003290 | TIPs Metabolomics (urine) | Urine | Human | Vanderbilt University Medical Center | LC-MS | |
| ST002019 | AN003289 | TIPs Metabolomics (blood) | Blood | Human | Vanderbilt University Medical Center | LC-MS | |
| ST002018 | AN003288 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) | Feces | Human | Vanderbilt University Medical Center | LC-MS | |
| ST002017 | AN003287 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) | Blood | Human | Vanderbilt University Medical Center | LC-MS | |
| ST001940 | AN003155 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | LC-MS |
| ST001940 | AN003156 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | LC-MS |
| ST001940 | AN003157 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | LC-MS |
| ST001940 | AN003158 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | LC-MS |
| ST001827 | AN002963 | The pregnancy metabolome from a multi-ethnic pregnancy cohort | Blood | Human | Icahn School of Medicine at Mount Sinai | LC-MS | |
| ST001749 | AN002850 | REACH Metabolomics Study | Blood | Human | Alzheimers disease | University of Wisconsin-Madison | LC-MS |
| ST001639 | AN002683 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort | Blood | Human | COPD | National Jewish Health | LC-MS |
| ST001517 | AN002519 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-III) | Blood | Human | Malaria | New York University Abu Dhabi | LC-MS |
| ST001516 | AN002516 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-II) | Blood | Human | Malaria | New York University Abu Dhabi | LC-MS |
| ST001515 | AN002513 | A Metabolomic Signature of Glucagon Action in Healthy Individuals with Overweight/Obesity Humans | Blood | Human | Obesity | Translational Research Institute- AdventHealth Orlando | LC-MS |
| ST001412 | AN002362 | Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures | Blood | Human | Obesity | University of Michigan | LC-MS |
| ST001411 | AN002361 | Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark | Blood | Human | Obesity | University of Michigan | LC-MS |
| ST001400 | AN002341 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria | Blood | Human | Malaria | New York University Abu Dhabi | LC-MS |
| ST001212 | AN002046 | Fish-oil supplementation in pregnancy, child metabolomics and asthma risk | Blood | Human | University of Copenhagen | LC-MS | |
| ST000976 | AN001597 | GC6-74 matabolomic of TB (Part 3: Plasma_RPMI) | Blood | Human | Tuberculosis | Max Planck Institute for Infection Biology | LC-MS |
| ST000975 | AN001596 | GC6-74 metabolomics of TB vs healthy (Part 2: Serum) | Blood | Human | Tuberculosis | Max Planck Institute for Infection Biology | LC-MS |
| ST000974 | AN001595 | GC6-74 matabolomic of TB (Part 1: Plasma) | Blood | Human | Tuberculosis | Max Planck Institute for Infection Biology | LC-MS |
| ST000899 | AN001464 | Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling | Blood | Human | Inflammatory bowel disease | Vanderbilt University Medical Center | LC-MS |
| ST000567 | AN000871 | Large Scale HILIC Profiling of the Effects of Curcumin Supplementation of Older Adults: Relation to Vascular Function | Blood | Human | Heart disease | Mayo Clinic | LC-MS |
| ST000566 | AN000869 | Large Scale C18 Profiling of the Effects of Curcumin Supplementation of Older Adults: Relation to Vascular Function | Blood | Human | Heart disease | Mayo Clinic | LC-MS |
| ST000356 | AN000583 | GC/MS and LC/MS metabolomics profiling for breast cancer serum data and control serum data | Blood | Human | Cancer | University of Hawaii | GC-MS/LC-MS |
